# AbbVie Inc.: Form 8-K, filed May 11, 2022

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2022-05-11
- Accepted by EDGAR: May 11, 2022, 17:06 ET
- Period: 2022-05-06
- Accession: 0001104659-22-058862
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000110465922058862/tm2215079d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000110465922058862/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000110465922058862/tm2215079d1_8k.htm

Filed May 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-058862. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
